# Roberto Hegg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/roberto-hegg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,887 |
| Field | Advanced Breast Cancer Therapies |
| h-index | 42 |
| i10-index | 61 |
| Last Known Institution | Universidade de São Paulo |
| OpenAlex ID | https://openalex.org/A5018564985 |
| ORCID iD | https://orcid.org/0000-0002-6453-8155 |
| Works | 186 |

## Researcher papers

- [Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/pertuzumab-trastuzumab-and-docetaxel-for-her2-positive-metastatic-breast-cancer/)
- [Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer](https://scholariq.org/papers/primary-results-from-impassion131-a-double-blind-placebo-controlled-randomised/)
- [Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study](https://scholariq.org/papers/adjuvant-abemaciclib-combined-with-endocrine-therapy-for-high-risk-early-breast/)

## Researcher topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Women's cancer prevention and management](https://scholariq.org/topics/women-s-cancer-prevention-and-management-2/)

## Researcher university

- [Universidade de São Paulo](https://scholariq.org/institutions/universidade-de-sao-paulo/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.